|Bid||3.0200 x 900|
|Ask||3.0400 x 800|
|Day's Range||2.8650 - 3.0700|
|52 Week Range||2.3800 - 10.2400|
|Beta (5Y Monthly)||0.77|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||12.50|
Evogene (EVGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NEW YORK, NY / ACCESSWIRE / March 3, 2021 / Evogene Ltd. (NASDAQ:EVGN) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 3, 2021 at 9:00 AM Eastern Time.